The advanced, metastatic differentiated thyroid cancers (DTCs) have a poor prognosis
mainly owing to radioactive iodine (RAI) refractoriness caused by decreased expression of …

… ) signal pathway due to mutations are critical in cancer progression. This review summarizes
the pathways involved in the molecular mechanisms of estrogen and ER in thyroid cancer, …

… pathways in thyroid cancer and to discuss the most recent targeted therapies and
immunotherapy for advanced thyroid cancer with a promising anti-tumor activity and clinical benefit. …

… the antitumor activity of vitamin C in thyroid cancer. … thyroid cancer 14 . We, therefore,
attempted to explore the effect of vitamin C on the activities of these two pathways in thyroid cancer …

… /Akt pathways. In conclusion, baicalein could suppress the growth of undifferentiated thyroid
cancer … The inhibition of the ERK and PI3K/Akt pathways may be involved in the mechanism. …

… Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. It has many types, the
Papillary thyroid cancer (PTC)(most common and follicular thyroid … signaling pathways such …

… The molecular pathogenesis of thyroid cancer involves dysregulation of the mitogen-… (PI3K)/AKT
pathways. Common activating mutations in the MAPK pathway include RET-PTC and …

… the activity of thyroid cancer-related signaling pathways such as MAPK pathway and RET …
have differential expression in different stages of thyroid cancer. Assessment of serum levels of …

… detected in thyroid cancer, we will initially discuss RTK-related upstream signaling pathways
involved in tumorigenesis and subsequently focus on the effectors of these pathways. …

… )/AKT/mTOR pathway has been reported in thyroid cancer pathogenesis. Everolimus is a
Sirolimus-derived mTOR inhibitor, whose activity against several thyroid cancer cell lines has …